Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Jasper Therapeutics, Inc.(JSPR) | 928,964 | 928,964 | 0 | $27.27M | $21.09M | 40.07% | -$6.19M |
| Korro Bio, Inc.(KRRO) | 368,085 | 368,085 | 0 | $33.13M | $12.47M | 23.69% | -$20.66M |
| Tourmaline Bio Inc | 741,691 | 741,691 | 0 | $16.98M | $9.54M | 18.13% | -$7.45M |
| Hillevax Inc | 558,923 | 558,923 | 0 | $9.29M | $8.08M | 15.36% | -$1.21M |
| Ventyx Biosciences Inc | 412,225 | 412,225 | 0 | $2.27M | $952.2K | 1.81% | -$1.31M |
| Kezar Life Sciences Inc | 828,711 | 828,711 | 0 | $747.2K | $497.2K | 0.94% | -$249.9K |